NYR-BI03

· Nyrada Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NYR-BI03, covering 2025-07-29 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety, Tolerability, and Pharmacokinetics of NYR-BI03 in Healthy Participants [Phase 1]